Matrix Pharmacorp 11.95% May 2029 NCD (INE0U0U07019)

CRISIL AA- · NSDL record, 2024 Secured NCD

Matrix Pharmacorp Private Limited

Secured, Taxable, Redeemable NCD

Browse: bonds maturing in 2029

2 more bonds from Matrix Pharmacorp Private Limited →

Current YTM

—

No market YTM available

Coupon Rate

11.95%

Per annum

Maturity Date

31 May 2029

2.6 Yrs to Maturity

Interest Payment

Quarterly

Frequency

Face Value

₹48,950

Per Bond

Issuer events

Last 90 days · company disclosures to the exchanges and agency announcements. Not our assessment.

30 Oct 2026 New rating assigned to A1+ CRISIL

Market Position

YTM (Annual)

—

No trade with a usable price on record

10Y G-Sec Benchmark

7.19%

Reference point, not this bond's tenor

Tenure

2.6 Years

Remaining to maturity

Price vs Yield

Price chart data not available

Secondary market trade data is collected over time as bonds trade on BSE/NSE. Needs at least 3 trade dates.

Showing last 10 trades.

Cashflow Timeline

30 Nov 2026

Interest Payment

₹1,462.38 / Bond

28 Feb 2027

Interest Payment

₹1,462.38 / Bond

31 May 2027

Interest Payment

₹1,462.38 / Bond

31 Aug 2027

Interest Payment

₹1,462.38 / Bond

30 Nov 2027

Interest Payment

₹1,462.38 / Bond

29 Feb 2028

Interest Payment

₹1,462.38 / Bond

31 May 2028

Interest Payment

₹1,462.38 / Bond

31 Aug 2028

Interest Payment

₹1,462.38 / Bond

…

+2 more coupons until 28 Feb 2029

₹1,462.38 each / Bond

31 May 2029

Final coupon + principal

₹50,412.38 / Bond

₹1,462.38 coupon + ₹48,950 face value

11 coupons remaining, the last paid with principal at maturity · per ₹48,950 face value · projected dates

Bond Timeline

— Issue / Maturity | Coupon (projected) ┊ Today

Key Metrics

Coupon Rate

11.95%

YTM (Annual)

—

Credit Rating

AA-

Rating on NSDL record (CRISIL, 2024)

Not a current agency rating; see below

Remaining Tenure

2.6 Years

AA- (CRISIL): Rating on NSDL record (CRISIL, 2024), dated 26 Apr 2024. The rating NSDL's debt master records for this instrument, often from the time of issue. No current rating from an agency or exchange is on file, so it may be out of date.

Advanced metrics

Modified Duration

—

Macaulay Duration

—

Issue Size

₹200 Cr

Face Value

₹48,950

Per bond. Exchange lot size not on file; check the offer document.

Market Characteristics

Modified Duration

—

Price sensitivity per 1% yield move

Payment Frequency

Quarterly

Last Trade

—

No recorded trades

Trades (30 Days)

Exchange-reported sessions

Security Status

Secured

Callable

Observations

This bond is secured.
No secondary-market trades recorded in the last 30 days.
Coupon is 1.75 percentage points above the median for tracked NCD bonds. (based on 20,403 tracked NCD bonds with a stated coupon)

Structured Overview

Data as of 16 Jul 2026

Issuer

Matrix Pharmacorp Private Limited

Instrument Type

NCD

Issue Date

31 May 2024

Day Count Convention

—

Listed Exchange

Not listed

Call / Put Option

Callable & Puttable

Matrix Pharmacorp Private Limited issued Matrix Pharmacorp 11.95% May 2029 NCD, a secured NCD. It pays an 11.95% p.a. coupon, quarterly. Principal is repaid at maturity. The issuer holds the right to redeem it before the maturity date.

Rating Action History

1 actions

Agency actions on Matrix Pharmacorp Private Limited and its instruments, not only this bond. Rows marked “This bond” carry this ISIN or an exchange filing that names it.

Date	Agency	Action	Rating	Outlook	Rationale
2026-10-30	CRISIL	Initial	A1+	—	View →

Issuer health card · ratings, payment record, defaults, trading, filings 1 item to look at →

Rating Actions on Matrix Pharmacorp Private Limited

last 12 months

Agencies rate the issuer and its instruments together; an action may cover bank loans or other instruments rather than this bond. This bond marks actions that carry this ISIN or whose exchange filing names it.

Date	Agency	Action	Rating	Rationale
2026-10-30	CRISIL	Initial	A1+	View →

Alert me about Matrix Pharmacorp Private Limited An email when a rating agency acts on this issuer (including any cut to default grade D) or a payment is disclosed late or short. Free, no account needed.

Data Coverage

Dataset	Records	Detail	Freshness
Credit Ratings	1	CRISIL (NSDL record)	2024-04-26
Rating Actions History	1	—	2026-10-30
Secondary-Market Trades	0	—	—
Reg52(4) Payment Disclosures	0	—	—

No current rating from an agency or exchange on file; the rating shown is the one NSDL's debt master records, often from the time of issue.
No secondary-market trade with a usable price on record, so no market yield or spread is shown.

Documents

CRISIL Rating Rationale (30 Oct 2026)

Entity metadata

Source: NSDL debt master
Last Updated: 16 Jul 2026

Risk warning: This page is for informational purposes only. Bond investments carry credit risk, interest rate risk, and liquidity risk. Credit ratings reflect agency opinion at a point in time. Nothing here constitutes investment advice or a recommendation. Verify all details against the issuer's offer document and the exchange. RetailBonds.in is not a SEBI-registered intermediary. See our full disclaimer.

Frequently Asked Questions

What is the coupon rate on Matrix Pharmacorp 11.95% May 2029 NCD?

Matrix Pharmacorp 11.95% May 2029 NCD carries a coupon of 11.95%, paid quarterly, on a face value of ₹48,950.

When does Matrix Pharmacorp 11.95% May 2029 NCD mature?

Matrix Pharmacorp 11.95% May 2029 NCD matures on 31 May 2029, 2.6 years from today.

What is Matrix Pharmacorp 11.95% May 2029 NCD rated?

No current rating from an agency or exchange is on file for Matrix Pharmacorp 11.95% May 2029 NCD. NSDL's debt master records a rating of AA- by CRISIL, dated 26 Apr 2024, often from the time of issue, so it may be out of date.

Is Matrix Pharmacorp 11.95% May 2029 NCD secured?

Matrix Pharmacorp 11.95% May 2029 NCD is a secured bond.

Can Matrix Pharmacorp 11.95% May 2029 NCD be called or put back early?

Matrix Pharmacorp 11.95% May 2029 NCD has both a call option, letting the issuer redeem it early, and a put option, letting holders require early repurchase, on scheduled dates.

Where does Matrix Pharmacorp 11.95% May 2029 NCD trade?

Matrix Pharmacorp 11.95% May 2029 NCD is not listed on a stock exchange, so there is no exchange price for it.

More Bonds from This Issuer

Matrix Pharmacorp 10.00% Nov 2028 NCD

INE0U0U07035

AA- NSDL record, 2024

Coupon

10.00%

Maturity

30 Nov 2028

View Details

Matrix Pharmacorp 6.00% Jun 2035 CCD

INE0U0U08017

Coupon

6.00%

Maturity

03 Jun 2035

View Details

Compare (/) Compare Bonds

Comparable NCDs maturing near 2029

Active bonds from other issuers with maturity within 12 months of this one, listed first when they are in the same face-value band as this bond and traded in the last 30 days, then by closest coupon to 11.95%. For comparison only, not a recommendation.

Bond	Issuer	Rating	Coupon	Maturity
INE0Z4Q07527	Anson Fincorp Private Limited	—	12.00%	2028-06-02
INE0Z4Q07147	Anson Fincorp Private Limited	—	12.00%	2028-06-25
INE0Z4Q07188	Anson Fincorp Private Limited	—	12.00%	2028-07-31
INE0Z4Q07253	Anson Fincorp Private Limited	—	12.00%	2028-08-29
INE0Z4Q07337	Anson Fincorp Private Limited	—	12.00%	2028-10-14
INE0Z4Q07410	Anson Fincorp Private Limited	—	12.00%	2028-10-28

← Back to screener